62 Results

People

  1. O'Reilly
    O'Reilly
  2. Sadelain
    Sadelain
  3. Riviere
    Riviere
  4. Doubrovina
    Doubrovina
  5. Scheinberg
    Scheinberg
  6. Kernan
    Kernan
  7. Koehne
    Koehne
  8. Curran
    Curran
  9. Gallardo
    Gallardo
  10. Brentjens
    Brentjens

Groups

  1. Department of Medicine (62)
  2. GSK Faculty (62)
  3. Hematologic Malignancies, Division of (62)
  4. Immunology Program Faculty (62)
  5. Molecular Pharmacology and Chemistry Program Faculty (62)
  6. Pediatrics, Department of (62)
  7. Sloan Kettering Institute Faculty (62)
  8. Stem Cell Transplantation and Cellular Therapy Service (62)
  9. Tow Center for Developmental Oncology (TCDO) (62)
  10. Center for Hematologic Malignancies (60)
  1. "GSK Faculty"
  2. "Hematologic Malignancies, Division of"
  3. "Molecular Pharmacology and Chemistry Program Faculty"
  4. "Sloan Kettering Institute Faculty"
  5. "Richard O'Reilly"
Formats
  1. Meeting Abstract (38)
  2. Journal Article (24)
Groups
  1. Department of Medicine (62)
  2. GSK Faculty (62)
  3. Hematologic Malignancies, Division of (62)
  4. Immunology Program Faculty (62)
  5. Molecular Pharmacology and Chemistry Program Faculty (62)
  6. Pediatrics, Department of (62)

More Groups

People
  1. Richard O'Reilly (62)
  2. Michel Sadelain (35)
  3. Isabelle Riviere (18)
  4. Ekaterina Doubrovina (17)
  5. David Scheinberg (14)
  6. Guenther Koehne (13)

More People

Years
  1. 2023 (3)
  2. 2022 (1)
  3. 2020 (1)
  4. 2019 (3)
  5. 2017 (1)
  6. 2016 (3)

More Years

Publications
  1. Blood (29)
  2. Biology of Blood and Marrow Transplantation (3)
  3. Bone Marrow Transplantation (3)
  4. Cancer Research (2)
  5. Experimental Hematology (2)
  6. Nature Biotechnology (2)

More Publications

Publishers
  1. American Society of Hematology (29)
  2. American Association for Cancer Research (6)
  3. Elsevier Inc. (5)
  4. Nature Publishing Group (5)
  5. Elsevier Science, Inc. (3)
  6. Academic Press Inc., Elsevier Science (1)

More Publishers

Results (62)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Neopeptide diversity and similarity to the unmutated immunopeptidome is associated with response to immune checkpoint blockade therapy
    Meeting Abstract

    Klatt, M.; Molvi, Z.; Panageas, K.; Wells, D.; Hellmann, M.; Merghoub, T.; Wolchok, J.; O'Reilly, R.; Keller, U.; Scheinberg, D.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • The landscape of MHC-presented phosphopeptides yields actionable shared tumor antigens for cancer immunotherapy across multiple HLA alleles
    Journal Article

    Molvi, Z.; Klatt, M. G.; Dao, T.; Urraca, J.; Scheinberg, D. A.; O'Reilly, R. J.
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • A TCR mimic monoclonal antibody reactive with the "public" phosphoneoantigen pIRS2/HLA-A*02:01 complex
    Journal Article

    Dao, T.; Mun, S. S.; Molvi, Z.; Korontsvit, T.; Klatt, M. G.; Khan, A. G.; Nyakatura, E. K.; Pohl, M. A.; White, T. E.; Balderes, P. J.; more...
    JCI Insight (2022)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • High dose cyclophosphamide and pre-treatment disease burden dictate response and survival in a multicenter clinical trial using CD19-specific CAR T cells for relapsed/refractory B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Park, J. H.; Sauter, C. S.; Smith, E. L.; Boulad, F.; Cancio, M. I.; Forlenza, C.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8(+) T cells for adoptive immunotherapy of cancer and infections
    Journal Article

    Hasan, A. N.; Selvakumar, A.; Shabrova, E.; Liu, X. R.; Afridi, F.; Heller, G.; Riviere, I.; Sadelain, M.; Dupont, B.; O'Reilly, R. J.
    Clinical and Experimental Immunology (2016)

    Fulltext@MSK | Save